Respiratory onset of amyotrophic lateral sclerosis in a pregnant woman with a novel SOD1 mutation.

With the advent of gene therapies for amyotrophic lateral sclerosis (ALS), the importance of gene testing in ALS is increasing. This will likely lead to the identification of new variants for which the pathogenicity is not established. We aimed to study the pathogenicity of a newly identified variant in superoxide dismutase 1 (SOD1). Gene testing was performed using Sanger sequencing. SOD1 activity in erythrocytes was measured using spectrophotometry. Postmortem brain and spinal cord sections were stained with antibodies against phospho-TDP-43 and SOD1. We identified a novel c.416G>T (p.Gly139Val) mutation in SOD1, which caused a rapidly progressive respiratory onset form of ALS. The mutation resulted in a 50% drop of SOD1 activity. Postmortem examination confirmed the absence of TDP-43 pathology and displayed typical SOD1 inclusions in remaining motor neurons, confirming the pathogenic nature of the mutation. Novel variants of unknown pathogenicity will be identified as a result of a surge in gene testing in people with ALS. An in-depth study of a newly identified p.Gly139Val mutation in SOD1 confirmed the pathogenicity of this mutation. Future patients with this particular mutation should qualify for SOD1 silencing or editing therapies. © 2021 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.

Citation

Pegah Masrori, Simona Ospitalieri, Karin Forsberg, Thomas G Moens, Koen Poesen, Valerie Race, Thomas Brännström, Peter M Andersen, Dietmar R Thal, Philip Van Damme. Respiratory onset of amyotrophic lateral sclerosis in a pregnant woman with a novel SOD1 mutation. European journal of neurology. 2022 Apr;29(4):1279-1283

Mesh Tags

Substances

PMID: 35253968

search → result